BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20:1525-1528. [PMID: 11313896 DOI: 10.1038/sj.onc.1204234] [Cited by in Crossref: 192] [Cited by in F6Publishing: 213] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Yan Q, Wu Y, Li D, Li Y, Stefan-van Staden R. A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/2830634] [Reference Citation Analysis]
2 Alshammari E, Zhang Y, Sobota J, Yang Z. Aberrant DNA Methylation of Tumor Suppressor Genes and Oncogenes as Cancer Biomarkers. In: Sahu SC, editor. Genomic and Epigenomic Biomarkers of Toxicology and Disease. Wiley; 2022. pp. 251-71. [DOI: 10.1002/9781119807704.ch12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol 2022;14:175883592210830. [DOI: 10.1177/17588359221083049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Vaiphei K. Morphological Aspect of Gastric Carcinomas. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_15] [Reference Citation Analysis]
5 Rubtsova SN, Zhitnyak IY, Gloushankova NA. Dual role of E-cadherin in cancer cells. Tissue Barriers 2021;:2005420. [PMID: 34821540 DOI: 10.1080/21688370.2021.2005420] [Reference Citation Analysis]
6 Sremac M, Paic F, Grubelic Ravic K, Serman L, Pavicic Dujmovic A, Brcic I, Krznaric Z, Nikuseva Martic T. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma. Oncol Lett 2021;22:822. [PMID: 34691249 DOI: 10.3892/ol.2021.13083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
8 Ithurralde-Argerich J, Rosner L, Rizzolo M, Faerberg A, Puma R, Ferro D, Duque C, Kujaruk M, Cuenca-Abente F. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers. J Laparoendosc Adv Surg Tech A 2021;31:729-37. [PMID: 34097461 DOI: 10.1089/lap.2021.0239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Danilova NV, Mikhailov IA, Oleynikova NA, Malkov PG. [E-cadherin expression in tumor emboli in gastric cancer]. Arkh Patol 2021;83:11-9. [PMID: 34041891 DOI: 10.17116/patol20218303111] [Reference Citation Analysis]
10 Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, Rebuzzi F, Canale M, Pignatta S, Ferracci E, Martinelli G, Ranzani GN, Oliveira C, Calistri D, Ulivi P. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel) 2021;14:457. [PMID: 34066170 DOI: 10.3390/ph14050457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Nikaido M, Kakiuchi N, Miyamoto S, Hirano T, Takeuchi Y, Funakoshi T, Yokoyama A, Ogasawara T, Yamamoto Y, Yamada A, Setoyama T, Shimizu T, Kato Y, Uose S, Sakurai T, Minamiguchi S, Obama K, Sakai Y, Muto M, Chiba T, Ogawa S, Seno H. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer 2021;24:1102-14. [PMID: 33961152 DOI: 10.1007/s10120-021-01191-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Takeshima H, Niwa T, Yamashita S, Takamura-Enya T, Iida N, Wakabayashi M, Nanjo S, Abe M, Sugiyama T, Kim YJ, Ushijima T. TET repression and increased DNMT activity synergistically induce aberrant DNA methylation. J Clin Invest 2020;130:5370-9. [PMID: 32663196 DOI: 10.1172/JCI124070] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
13 Özsoy M, Yaylak F. Stomach and Duodenum Resections for Genetic Predispositions. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_14] [Reference Citation Analysis]
14 Casalino L, Verde P. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis. Genes (Basel) 2020;11:E922. [PMID: 32806509 DOI: 10.3390/genes11080922] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
15 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
16 Corso G, Figueiredo J, De Angelis SP, Corso F, Girardi A, Pereira J, Seruca R, Bonanni B, Carneiro P, Pravettoni G, Guerini Rocco E, Veronesi P, Montagna G, Sacchini V, Gandini S. E-cadherin deregulation in breast cancer. J Cell Mol Med 2020;24:5930-6. [PMID: 32301282 DOI: 10.1111/jcmm.15140] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
17 Wang SC, Yeu Y, Hammer STG, Xiao S, Zhu M, Hong C, Clemenceau JR, Yoon LY, Nassour I, Shen J, Agarwal D, Reznik SI, Mansour JC, Yopp AC, Zhu H, Hwang TH, Porembka MR. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants. Cancer Res 2020;80:2114-24. [PMID: 32269045 DOI: 10.1158/0008-5472.CAN-19-2918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
18 Renaud F, Svrcek M. [Hereditary gastric cancer: Challenges for the pathologist in 2020]. Ann Pathol 2020;40:95-104. [PMID: 32147190 DOI: 10.1016/j.annpat.2020.02.007] [Reference Citation Analysis]
19 Moridnia A, Tabatabaiefar MA, Zeinalian M, Minakari M, Kheirollahi M, Moghaddam NA. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer. J Gastrointest Cancer 2019;50:420-7. [PMID: 29577179 DOI: 10.1007/s12029-018-0082-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
20 Zhang YK, Wang H, Guo YW, Yue Y. Novel role of Snail 1 in promoting tumor neoangiogenesis. Biosci Rep 2019;39:BSR20182161. [PMID: 30975732 DOI: 10.1042/BSR20182161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kojima K, Minatani N, Ushiku H, Ishii S, Tanaka T, Yokoi K, Nishizawa N, Ooizumi Y, Igarashi K, Hosoda K, Moriya H, Mieno H, Watanabe M, Yamashita K. Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin. Oncotarget. 2019;10:2423-2434. [PMID: 31069006 DOI: 10.18632/oncotarget.26814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Korivi BR, Faria S, Aly A, Sun J, Patnana M, Jensen CT, Wagner-Bartak N, Bhosale PR. Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites. Clin Imaging 2019;56:33-40. [PMID: 30870726 DOI: 10.1016/j.clinimag.2019.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
23 Bustos-Carpinteyro AR, Oliveira C, Sousa A, Oliveira P, Pinheiro H, Carvalho J, Magaña-Torres MT, Flores-Miramontes MG, Aguilar-Lemarroy A, Jave-Suárez LF, Peregrina-Sandoval J, Cruz-Ramos JA, Sánchez-López JY. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer. BMC Cancer 2019;19:69. [PMID: 30642281 DOI: 10.1186/s12885-019-5294-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
24 Rotondo R, Rizzolio F, Perin T, Berretta M, Zanconati F, Giordano A, Canzonieri V. Pathological Diagnosis and Classification of Gastric Epithelial Tumours. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Setoyama T, Miyamoto S, Nikaido M, Seno H. New Perspectives in Gastric Cancer: Helicobacter pylori-Uninfected Pure Signet Ring Cell Carcinoma. Alcoholic/Non-Alcoholic Digestive Diseases 2019. [DOI: 10.1007/978-981-13-1465-0_4] [Reference Citation Analysis]
26 Nasri S, Humara B, Anjomshoaa A, Moradi N, Gholipour N, Mashjoor S, Zhang P. Early Hereditary Diffuse Gastric Cancer (eHDGC) is Characterized by Subtle Genomic Instability and Active DNA Damage Response. Pathol Oncol Res 2019;25:711-21. [PMID: 30547291 DOI: 10.1007/s12253-018-0547-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
27 Cho SJ, Yoon C, Lee JH, Chang KK, Lin JX, Kim YH, Kook MC, Aksoy BA, Park DJ, Ashktorab H, Smoot DT, Schultz N, Yoon SS. KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition. Clin Cancer Res 2018;24:6556-69. [PMID: 30108106 DOI: 10.1158/1078-0432.CCR-17-1679] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
28 Mohsenzadeh M, Sadeghi RN, Vahedi M, Kamani F, Hashemi M, Asadzadeh H, Zali MR. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: Association with histological type and clinical outcomes. Cancer Biomark 2017;20:7-15. [PMID: 28759951 DOI: 10.3233/CBM-160331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Wong CC, Li W, Chan B, Yu J. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Semin Cancer Biol 2019;55:90-105. [PMID: 29665409 DOI: 10.1016/j.semcancer.2018.04.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
30 Yoshii T, Miyagi Y, Nakamura Y, Kobayashi O, Kameda Y, Ohkawa S. Pilot Research for the Correlation between the Expression Pattern of E-cadherin-β-Catenin Complex and Lymph Node Metastasis in Early Gastric Cancer. Tumori 2013;99:234-8. [DOI: 10.1177/030089161309900219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
31 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
32 Niller HH, Minarovits J. Epigenetics and Human Infectious Diseases. Epigenetics in Human Disease 2018. [DOI: 10.1016/b978-0-12-812215-0.00021-2] [Reference Citation Analysis]
33 Ribeiro U, Perrotta FS. The Role of Surgery. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_6] [Reference Citation Analysis]
34 Sailer V. Metastatic Prostate Cancer. Molecular Pathology Library 2018. [DOI: 10.1007/978-3-319-64096-9_17] [Reference Citation Analysis]
35 Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Ann Surg 2017;266:1006-12. [PMID: 27759617 DOI: 10.1097/SLA.0000000000002030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
36 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Menbari MN, Nasseri S, Menbari N, Mehdiabadi R, Alipur Y, Roshani D. The -160 (C>A) CDH1 Gene Promoter Polymorphism and Its Relationship with Survival of Patients with Gastric Cancer in Kurdistan. Asian Pac J Cancer Prev 2017;18:1561-5. [PMID: 28669168 DOI: 10.22034/APJCP.2017.18.6.1561] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
38 Alvizi L, Ke X, Brito LA, Seselgyte R, Moore GE, Stanier P, Passos-Bueno MR. Differential methylation is associated with non-syndromic cleft lip and palate and contributes to penetrance effects. Sci Rep 2017;7:2441. [PMID: 28550290 DOI: 10.1038/s41598-017-02721-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
39 Gan WJ, Wang JR, Zhu XL, He XS, Guo PD, Zhang S, Li XM, Li JM, Wu H. RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis. J Exp Clin Cancer Res 2016;35:164. [PMID: 27756432 DOI: 10.1186/s13046-016-0441-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
40 Maiuri AR, O'Hagan HM. Interplay Between Inflammation and Epigenetic Changes in Cancer. Prog Mol Biol Transl Sci 2016;144:69-117. [PMID: 27865469 DOI: 10.1016/bs.pmbts.2016.09.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
41 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
42 Higuchi K, Inokuchi M, Takagi Y, Ishikawa T, Otsuki S, Uetake H, Kojima K, Kawano T. Cadherin 5 expression correlates with poor survival in human gastric cancer. J Clin Pathol 2017;70:217-21. [PMID: 27466381 DOI: 10.1136/jclinpath-2016-203640] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
43 Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11:2959-2964. [PMID: 27123046 DOI: 10.3892/ol.2016.4337] [Cited by in Crossref: 108] [Cited by in F6Publishing: 116] [Article Influence: 15.4] [Reference Citation Analysis]
44 Eftang LL, Klajic J, Kristensen VN, Tost J, Esbensen QY, Blom GP, Bukholm IR, Bukholm G. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer. BMC Cancer 2016;16:225. [PMID: 26984265 DOI: 10.1186/s12885-016-2247-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
45 Albrecht LV, Green KJ, Dubash AD. Cadherins in Cancer. The Cadherin Superfamily 2016. [DOI: 10.1007/978-4-431-56033-3_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
46 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 168] [Article Influence: 19.1] [Reference Citation Analysis]
47 Brzozowa M, Michalski M, Wyrobiec G, Piecuch A, Dittfeld A, Harabin-Słowińska M, Boroń D, Wojnicz R. The role of Snail1 transcription factor in colorectal cancer progression and metastasis. Contemp Oncol (Pozn) 2015;19:265-70. [PMID: 26557772 DOI: 10.5114/wo.2014.42173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yu Q, Guo Q, Chen L, Liu S. Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review. Drug Des Devel Ther 2015;9:2171-8. [PMID: 25931811 DOI: 10.2147/DDDT.S78537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
49 Zeng W, Zhu J, Shan L, Han Z, Aerxiding P, Quhai A, Zeng F, Wang Z, Li H. The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review. Drug Des Devel Ther. 2015;9:2149-2157. [PMID: 25926721 DOI: 10.2147/dddt.s75429] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
50 Zhao Y, Feng F, Zhou YN. Stem cells in gastric cancer. World J Gastroenterol 2015; 21(1): 112-123 [PMID: 25574084 DOI: 10.3748/wjg.v21.i1.112] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
51 Ketner EP, Chu QD, Karpeh MS, Khushalani NI. Gastric Cancer. Surgical Oncology 2015. [DOI: 10.1007/978-1-4939-1423-4_9] [Reference Citation Analysis]
52 Pattison S, Boussioutas A. Pathophysiology of Hereditary Diffuse Gastric Cancer. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol 2014;28:1055-68. [PMID: 25439071 DOI: 10.1016/j.bpg.2014.09.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
54 McCole DF. IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis 2014;20:1829-49. [PMID: 25215613 DOI: 10.1097/MIB.0000000000000090] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 11.6] [Reference Citation Analysis]
55 Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol 2014;15:428. [PMID: 25315765 DOI: 10.1186/s13059-014-0428-9] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 10.1] [Reference Citation Analysis]
56 Cho M, Eze O, Xu R. Molecular genetics of gastric adenocarcinoma in clinical practice. World J Med Genet 2014; 4(3): 58-68 [DOI: 10.5496/wjmg.v4.i3.58] [Reference Citation Analysis]
57 Muratani M, Deng N, Ooi WF, Lin SJ, Xing M, Xu C, Qamra A, Tay ST, Malik S, Wu J, Lee MH, Zhang S, Tan LLC, Chua H, Wong WK, Ong HS, Ooi LL, Chow PK, Chan WH, Soo KC, Goh LK, Rozen S, Teh BT, Yu Q, Ng HH, Tan P. Nanoscale chromatin profiling of gastric adenocarcinoma reveals cancer-associated cryptic promoters and somatically acquired regulatory elements. Nat Commun 2014;5. [DOI: 10.1038/ncomms5361] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
58 Park JW, Jang SH, Park DM, Lim NJ, Deng C, Kim DY, Green JE, Kim HK. Cooperativity of E-cadherin and Smad4 Loss to promote diffuse-type gastric adenocarcinoma and metastasis. Mol Cancer Res. 2014;12:1088-1099. [PMID: 24784840 DOI: 10.1158/1541-7786.mcr-14-0192-t] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
59 Lee YS, Cho YS, Lee GK, Lee S, Kim YW, Jho S, Kim HM, Hong SH, Hwang JA, Kim SY. Genomic profile analysis of diffuse-type gastric cancers. Genome Biol. 2014;15:R55. [PMID: 24690483 DOI: 10.1186/gb-2014-15-4-r55] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
60 Yoda Y, Takeshima H, Niwa T, Kim JG, Ando T, Kushima R, Sugiyama T, Katai H, Noshiro H, Ushijima T. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 2015;18:65-76. [DOI: 10.1007/s10120-014-0348-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 8.2] [Reference Citation Analysis]
61 Pinho SS, Carvalho S, Marcos-pinto R, Magalhães A, Oliveira C, Gu J, Dinis-ribeiro M, Carneiro F, Seruca R, Reis CA. Gastric cancer: adding glycosylation to the equation. Trends in Molecular Medicine 2013;19:664-76. [DOI: 10.1016/j.molmed.2013.07.003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
62 Zhuang MK, Chen FL. Biomarkers of epithelial-mesenchymal transition in gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(30): 3204-3210 [DOI: 10.11569/wcjd.v21.i30.3204] [Reference Citation Analysis]
63 McVeigh TP, Choi JK, Miller NM, Green AJ, Kerin MJ. Lobular breast cancer in a CDH1 splice site mutation carrier: case report and review of the literature. Clin Breast Cancer 2014;14:e47-51. [PMID: 24333020 DOI: 10.1016/j.clbc.2013.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
64 Carneiro P, Figueiredo J, Bordeira-Carriço R, Fernandes MS, Carvalho J, Oliveira C, Seruca R. Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 2013;17:1187-201. [PMID: 23957294 DOI: 10.1517/14728222.2013.827174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
65 Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta. 2013;424:53-65. [PMID: 23669186 DOI: 10.1016/j.cca.2013.05.002] [Cited by in Crossref: 228] [Cited by in F6Publishing: 211] [Article Influence: 22.8] [Reference Citation Analysis]
66 Konno-Shimizu M, Yamamichi N, Inada K, Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I, Yamamichi-Nishina M, Nakayama C, Ono S, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K. Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis. PLoS One 2013;8:e56766. [PMID: 23451082 DOI: 10.1371/journal.pone.0056766] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
67 Nadauld LD, Ford JM. Molecular profiling of gastric cancer: toward personalized cancer medicine. J Clin Oncol. 2013;31:838-839. [PMID: 23341521 DOI: 10.1200/jco.2012.47.1714] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
68 Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013;31:868-875. [PMID: 23341533 DOI: 10.1200/jco.2012.44.4612] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 12.3] [Reference Citation Analysis]
69 Rhim AD, Sohal D, Nakagawa H. Molecular Mechanisms of Tumor Metastasis. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_13] [Reference Citation Analysis]
70 Carvalho J, Pinheiro H, Oliveira C. E-Cadherin Germline Mutations. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Festen EAM, Wijmenga C, Weersma RK. Inflammatory Bowel Disease. Genomic and Personalized Medicine 2013. [DOI: 10.1016/b978-0-12-382227-7.00073-2] [Reference Citation Analysis]
72 Graziosi L, Mencarelli A, Renga B, D'Amore C, Bruno A, Santorelli C, Cavazzoni E, Cantarella F, Rosati E, Donini A, Fiorucci S. Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. J Gastrointest Surg 2013;17:39-49; discussion p. 49. [PMID: 22948834 DOI: 10.1007/s11605-012-1996-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
73 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 2013;116:337-59. [PMID: 23481202 DOI: 10.1016/B978-0-12-394311-8.00015-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
74 Leite M, Corso G, Sousa S, Carvalho J, Roviello F, Oliveira C, Figueiredo C, Seruca R. Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_10] [Reference Citation Analysis]
75 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
76 Yantiss RK, Samowitz WS. Molecular Pathology of Gastrointestinal Cancer. Surg Pathol Clin 2012;5:821-42. [PMID: 26838505 DOI: 10.1016/j.path.2012.08.002] [Reference Citation Analysis]
77 Kim JG, Takeshima H, Niwa T, Rehnberg E, Shigematsu Y, Yoda Y, Yamashita S, Kushima R, Maekita T, Ichinose M. Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers. Cancer Lett. 2013;330:33-40. [PMID: 23196062 DOI: 10.1016/j.canlet.2012.11.022] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
78 Piazzi G, Bazzoli F, Ricciardiello L. Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle 2012;11:4323-7. [PMID: 23085543 DOI: 10.4161/cc.22388] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
79 Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R. E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett 2012;586:2981-9. [PMID: 22841718 DOI: 10.1016/j.febslet.2012.07.045] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
80 Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228:31-44. [PMID: 22450781 DOI: 10.1002/path.4032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 84] [Article Influence: 3.0] [Reference Citation Analysis]
81 Dauksa A, Gulbinas A, Barauskas G, Pundzius J, Oldenburg J, El-Maarri O. Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study. PLoS One. 2012;7:e37509. [PMID: 22629410 DOI: 10.1371/journal.pone.0037509] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
82 Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Sim窄es-Correia J, Oliveira MJ. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826:297-311. [PMID: 22613680 DOI: 10.1016/j.bbcan.2012.05.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 101] [Article Influence: 4.0] [Reference Citation Analysis]
83 Brooks GA, Enzinger PC, Fuchs CS. Adjuvant therapy for gastric cancer: revisiting the past to clarify the future. J Clin Oncol. 2012;30:2297-2299. [PMID: 22585690 DOI: 10.1200/jco.2012.42.4069] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
84 Yates C. Prostate tumor cell plasticity: a consequence of the microenvironment. Adv Exp Med Biol 2011;720:81-90. [PMID: 21901620 DOI: 10.1007/978-1-4614-0254-1_7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
85 Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y. Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J Gastroenterol. 2012;47:351-358. [PMID: 22402775 DOI: 10.1007/s00535-012-0565-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
86 Batlle E, Wilkinson DG. Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis. Cold Spring Harb Perspect Biol 2012;4:a008227. [PMID: 22214769 DOI: 10.1101/cshperspect.a008227] [Cited by in Crossref: 127] [Cited by in F6Publishing: 133] [Article Influence: 11.5] [Reference Citation Analysis]
87 Niller HH, Minarovits J. Epigenetics and Human Infectious Diseases. Epigenetics in Human Disease. Elsevier; 2012. pp. 415-41. [DOI: 10.1016/b978-0-12-388415-2.00021-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
88 Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S153-S163. [PMID: 22160243 DOI: 10.1007/s10120-011-0116-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
89 Luber B, Deplazes J, Keller G, Walch A, Rauser S, Eichmann M, Langer R, Höfler H, Hegewisch-Becker S, Folprecht G. Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). BMC Cancer. 2011;11:509. [PMID: 22152101 DOI: 10.1186/1471-2407-11-509] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
90 Sui H, Wang KB, Bai YX. DNA methylation and gastric cancer. Shijie Huaren Xiaohua Zazhi 2011; 19(32): 3347-3352 [DOI: 10.11569/wcjd.v19.i32.3347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Ferreira AC, Suriano G, Mendes N, Gomes B, Wen X, Carneiro F, Seruca R, Machado JC. E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Human Molecular Genetics 2012;21:334-43. [DOI: 10.1093/hmg/ddr469] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
92 Ottenhof NA, de Wilde RF, Morsink FH, de Leng WW, Ausems MG, Morreau H, van Hillegersberg R, Offerhaus GJ, Milne AN. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report. Hum Pathol 2012;43:457-61. [PMID: 21992816 DOI: 10.1016/j.humpath.2011.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
93 Svrcek M. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene]. Ann Pathol 2011;31:381-4. [PMID: 21982246 DOI: 10.1016/j.annpat.2011.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Balzer EM, Konstantopoulos K. Intercellular adhesion: mechanisms for growth and metastasis of epithelial cancers. Wiley Interdiscip Rev Syst Biol Med 2012;4:171-81. [PMID: 21913338 DOI: 10.1002/wsbm.160] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
95 Figueiredo J, Simões-Correia J, Söderberg O, Suriano G, Seruca R. ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones. PLoS One 2011;6:e23188. [PMID: 21853084 DOI: 10.1371/journal.pone.0023188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
96 van Sommeren S, Visschedijk MC, Festen EA, de Jong DJ, Ponsioen CY, Wijmenga C, Weersma RK. HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort. Inflamm Bowel Dis 2011;17:1714-8. [PMID: 21744425 DOI: 10.1002/ibd.21541] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
97 Mimata A, Fukamachi H, Eishi Y, Yuasa Y. Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci. 2011;102:942-950. [PMID: 21276134 DOI: 10.1111/j.1349-7006.2011.01890.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
98 Seto M, Ohta M, Ikenoue T, Sugimoto T, Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K. Reduced expression of RAS protein activator like-1 in gastric cancer. Int J Cancer. 2011;128:1293-1302. [PMID: 20473946 DOI: 10.1002/ijc.25459] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
99 Piazuelo MB, Epplein M, Correa P. Gastric cancer: an infectious disease. Infect Dis Clin North Am 2010;24:853-69, vii. [PMID: 20937454 DOI: 10.1016/j.idc.2010.07.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
100 Tao K, Wu C, Wu K, Li W, Han G, Shuai X, Wang G. Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer. Med Oncol 2012;29:107-12. [PMID: 21264540 DOI: 10.1007/s12032-010-9805-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
101 Jang B, Kim WH. Molecular Pathology of Gastric Carcinoma. Pathobiology 2011;78:302-10. [DOI: 10.1159/000321703] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 6.7] [Reference Citation Analysis]
102 Lee P, Jain S, Pincus MR, Xu R. Molecular Genetic Pathology of Solid Tumors. Henry's Clinical Diagnosis and Management by Laboratory Methods 2011. [DOI: 10.1016/b978-1-4377-0974-2.00076-2] [Reference Citation Analysis]
103 Yamashita K, Sakuramoto S, Watanabe M. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surg Today 2011;41:24-38. [DOI: 10.1007/s00595-010-4370-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
104 Klopfleisch R, von Euler H, Sarli G, Pinho SS, Gärtner F, Gruber AD. Molecular carcinogenesis of canine mammary tumors: news from an old disease. Vet Pathol 2011;48:98-116. [PMID: 21149845 DOI: 10.1177/0300985810390826] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 5.4] [Reference Citation Analysis]
105 Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631-639. [PMID: 21106365 DOI: 10.1016/j.ejca.2010.10.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
106 Svrcek M. [Hereditary gastric cancer: the pathologist's point of view]. Ann Pathol 2010;30:84-7. [PMID: 21055555 DOI: 10.1016/j.annpat.2010.08.005] [Reference Citation Analysis]
107 Hipp S, Berg D, Ergin B, Schuster T, Hapfelmeier A, Walch A, Avril S, Schmalfeldt B, Höfler H, Becker KF. Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients. Virchows Arch. 2010;457:705-713. [PMID: 20957493 DOI: 10.1007/s00428-010-0986-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
108 Becker K, Keller G. Gastric Cancer. eLS 2010. [DOI: 10.1002/9780470015902.a0006056.pub2] [Reference Citation Analysis]
109 da Cunha CB, Oliveira C, Wen X, Gomes B, Sousa S, Suriano G, Grellier M, Huntsman DG, Carneiro F, Granja PL. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest. 2010;90:1604-1614. [PMID: 20856229 DOI: 10.1038/labinvest.2010.155] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
110 Josson S, Sharp S, Sung SY, Johnstone PA, Aneja R, Wang R, Gururajan M, Turner T, Chung LW, Yates C. Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells. J Oncol 2010;2010:232831. [PMID: 20798867 DOI: 10.1155/2010/232831] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
111 Hu SL, Huang DB, Sun YB, Wu L, Xu WP, Yin S, Chen J, Jiang XD, Shen G. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. Med Oncol. 2011;28:447-454. [PMID: 20300977 DOI: 10.1007/s12032-010-9467-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
112 Pandalai PK, Yoon SS. Hereditary Diffuse Gastric Cancer. Principles of Clinical Cancer Genetics 2010. [DOI: 10.1007/978-0-387-93846-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Herceg Z, Boffetta P. Epigenetic Changes in Cancer: Role of Environment. Environmental Factors, Genes, and the Development of Human Cancers 2010. [DOI: 10.1007/978-1-4419-6752-7_7] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
114 Schrader K, Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010;155:33-63. [PMID: 20517687 DOI: 10.1007/978-1-4419-6033-7_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
115 Agarwal R, Mori Y, Cheng Y, Jin Z, Olaru AV, Hamilton JP, David S, Selaru FM, Yang J, Abraham JM. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells. PLoS One. 2009;4:e8002. [PMID: 19956721 DOI: 10.1371/journal.pone.0008002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 81] [Article Influence: 5.2] [Reference Citation Analysis]
116 Sharma RR, London MJ, Magenta LL, Posner MC, Roggin KK. Preemptive surgery for premalignant foregut lesions. J Gastrointest Surg 2009;13:1874-87. [PMID: 19513795 DOI: 10.1007/s11605-009-0935-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
117 Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol. 2009;1:a003129. [PMID: 20457567 DOI: 10.1101/cshperspect.a003129] [Cited by in Crossref: 420] [Cited by in F6Publishing: 471] [Article Influence: 30.0] [Reference Citation Analysis]
118 Nakamura Y, Migita T, Hosoda F, Okada N, Gotoh M, Arai Y, Fukushima M, Ohki M, Miyata S, Takeuchi K, Imoto I, Katai H, Yamaguchi T, Inazawa J, Hirohashi S, Ishikawa Y, Shibata T. Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Int J Cancer 2009;125:1859-67. [PMID: 19588488 DOI: 10.1002/ijc.24538] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
119 Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology. 2009;54:442-451. [PMID: 19309396 DOI: 10.1111/j.1365-2559.2009.03247.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 116] [Article Influence: 7.6] [Reference Citation Analysis]
120 Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009;136:2137-48. [PMID: 19269290 DOI: 10.1053/j.gastro.2009.02.065] [Cited by in Crossref: 120] [Cited by in F6Publishing: 128] [Article Influence: 8.6] [Reference Citation Analysis]
121 Pinho SS, Reis CA, Paredes J, Magalhães AM, Ferreira AC, Figueiredo J, Xiaogang W, Carneiro F, Gärtner F, Seruca R. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet 2009;18:2599-608. [PMID: 19403558 DOI: 10.1093/hmg/ddp194] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 5.8] [Reference Citation Analysis]
122 Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci. 2009;100:1151-1157. [PMID: 19432899 DOI: 10.1111/j.1349-7006.2009.01163.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
123 Oliveira C, Seruca R, Carneiro F. Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009;23:147-57. [PMID: 19414142 DOI: 10.1016/j.bpg.2009.02.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
124 Carneiro F, Oliveira C, Leite M, Seruca R. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol. 2008;25:274-287. [PMID: 19013893 DOI: 10.1053/j.semdp.2008.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
125 Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008;216:295-306. [PMID: 18788075 DOI: 10.1002/path.2426] [Cited by in Crossref: 99] [Cited by in F6Publishing: 110] [Article Influence: 6.6] [Reference Citation Analysis]
126 Buffart TE, Overmeer RM, Steenbergen RD, Tijssen M, van Grieken NC, Snijders PJ, Grabsch HI, van de Velde CJ, Carvalho B, Meijer GA. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer. 2008;99:1802-1807. [PMID: 19002170 DOI: 10.1038/sj.bjc.6604777] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
127 Hipp S, Walch A, Schuster T, Losko S, Laux H, Bolton T, Höfler H, Becker KF. Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer. J Cell Mol Med 2009;13:3858-67. [PMID: 19604315 DOI: 10.1111/j.1582-4934.2008.00526.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
128 Simões-Correia J, Figueiredo J, Oliveira C, van Hengel J, Seruca R, van Roy F, Suriano G. Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Hum Mol Genet. 2008;17:3566-3576. [PMID: 18772194 DOI: 10.1093/hmg/ddn249] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 3.3] [Reference Citation Analysis]
129 Nitti D, Mocellin S, Marchet A, Pilati P, Lise M. Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am 2008;17:467-83, vii. [PMID: 18486878 DOI: 10.1016/j.soc.2008.02.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
130 Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J, Burke W, Lynch HT, Garber JE, Huntsman DG. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 2008;7:73-82. [PMID: 18046629 DOI: 10.1007/s10689-007-9172-6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 6.3] [Reference Citation Analysis]
131 Fujii S, Ochiai A. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Sci. 2008;99:738-746. [PMID: 18377425 DOI: 10.1111/j.1349-7006.2008.00743.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 7.3] [Reference Citation Analysis]
132 Jenab M, McKay JD, Ferrari P, Biessy C, Laing S, Munar GM, Sala N, Peña S, Crusius JB, Overvad K, Jensen MK, Olsen A, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Georgila C, Psaltopoulou T, Mattiello A, Vineis P, Pala V, Palli D, Tumino R, Numans ME, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Sánchez MJ, Dorronsoro M, Sanchez CN, Quirós JR, Hallmans G, Stenling R, Manjer J, Régner S, Key T, Bingham S, Khaw KT, Slimani N, Rinaldi S, Boffetta P, Carneiro F, Riboli E, Gonzalez C. CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer 2008;44:774-80. [PMID: 18342503 DOI: 10.1016/j.ejca.2008.02.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
133 Hipp S, Walch A, Schuster T, Höfler H, Becker KF. Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clin Exp Metastasis 2008;25:679-83. [PMID: 18307046 DOI: 10.1007/s10585-008-9149-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
134 Pedrazzani C, Corso G, Marrelli D, Roviello F. E-cadherin and hereditary diffuse gastric cancer. Surgery. 2007;142:645-657. [PMID: 17981184 DOI: 10.1016/j.surg.2007.06.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
135 Yi Kim D, Kyoon Joo J, Kyu Park Y, Yeob Ryu S, Soo Kim H, Kyun Noh B, Hwa Lee K, Hyuk Lee J. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J Surg Oncol. 2007;96:429-435. [PMID: 17786966 DOI: 10.1002/jso.20732] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
136 Muretto P, Ruzzo A, Pizzagalli F, Graziano F, Maltese P, Zingaretti C, Berselli E, Donnarumma N, Magnani M. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients. Ann Oncol. 2008;19:516-519. [PMID: 17986624 DOI: 10.1093/annonc/mdm493] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
137 Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007;44:726-731. [PMID: 17660459 DOI: 10.1136/jmg.2007.051268] [Cited by in Crossref: 135] [Cited by in F6Publishing: 141] [Article Influence: 8.4] [Reference Citation Analysis]
138 Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M, Carneiro F, Becker KF. Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol. 2007;211:507-515. [PMID: 17299729 DOI: 10.1002/path.2138] [Cited by in Crossref: 116] [Cited by in F6Publishing: 130] [Article Influence: 7.3] [Reference Citation Analysis]
139 Zhao CH, Bu XM, Zhang N. Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer. World J Gastroenterol 2007; 13(15): 2214-2217 [PMID: 17465504 DOI: 10.3748/wjg.v13.i15.2214] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
140 Kaz A, Kim YH, Dzieciatkowski S, Lynch H, Watson P, Kay Washington M, Lin L, Grady WM. Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. Int J Cancer 2007;120:1922-9. [PMID: 17278092 DOI: 10.1002/ijc.22544] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
141 Corso G, Roviello F, Paredes J, Pedrazzani C, Novais M, Correia J, Marrelli D, Cirnes L, Seruca R, Oliveira C. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Eur J Surg Oncol. 2007;33:1061-1067. [PMID: 17434710 DOI: 10.1016/j.ejso.2007.03.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
142 Sezeur A, Schielke A, Larue L, Fléjou JF. [Hereditary diffuse gastric cancer]. Gastroenterol Clin Biol 2006;30:1205-13. [PMID: 17075480 DOI: 10.1016/s0399-8320(06)73513-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
143 Yasmeen A, Bismar TA, Al Moustafa AE. ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas. Future Oncol 2006;2:765-81. [PMID: 17155902 DOI: 10.2217/14796694.2.6.765] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
144 Carneiro F, Chaves P. Pathologic Risk Factors of Adenocarcinoma of the Gastric Cardia and Gastroesophageal Junction. Surgical Oncology Clinics of North America 2006;15:697-714. [DOI: 10.1016/j.soc.2006.07.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
145 Yuecheng Y, Hongmei L, Xiaoyan X. Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin Exp Metastasis. 2006;23:65-74. [PMID: 16826427 DOI: 10.1007/s10585-006-9020-3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
146 Sun D, Zhang Z, Van do N, Huang G, Ernberg I, Hu L. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol 2007;43:82-7. [PMID: 16807071 DOI: 10.1016/j.oraloncology.2006.01.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
147 Liu YC, Shen CY, Wu HS, Hsieh TY, Chan DC, Chen CJ, Yu JC, Yu CP, Harn HJ, Chen PJ, Hsieh CB, Chen TW, Hsu HM. Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas. World J Gastroenterol 2006; 12(14): 2168-2173 [PMID: 16610016 DOI: 10.3748/wjg.v12.i14.2168] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
148 Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol. 2006;14:21-33. [PMID: 16501831 DOI: 10.1177/106689690601400105] [Cited by in Crossref: 97] [Cited by in F6Publishing: 113] [Article Influence: 5.7] [Reference Citation Analysis]
149 Zhao CH, Zhang N, Bu XM, Li Y, Zhang HP. Multiple genes methylation detection in gastric cancer. Shijie Huaren Xiaohua Zazhi 2006; 14(10): 1004-1007 [DOI: 10.11569/wcjd.v14.i10.1004] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
150 Kaneda A. DNA Methylation and Gastric Carcinoma. The Diversity of Gastric Carcinoma. [DOI: 10.1007/4-431-27713-7_6] [Reference Citation Analysis]
151 Zazula M, Ferreira AM, Czopek JP, Kolodziejczyk P, Sinczak-kuta A, Klimkowska A, Wojcik P, Okon K, Bialas M, Kulig J, Stachura J. CDH1 Gene Promoter Hypermethylation in Gastric Cancer: Relationship to Goseki Grading, Microsatellite Instability Status, and EBV Invasion. Diagnostic Molecular Pathology 2006;15:24-9. [DOI: 10.1097/00019606-200603000-00004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
152 Becker K. Gastric Cancer. eLS 2006. [DOI: 10.1038/npg.els.0006056] [Reference Citation Analysis]
153 Mccaffrey JC. Aerodigestive Tract Invasion by Well-Differentiated Thyroid Carcinoma: Diagnosis, Management, Prognosis, and Biology: . The Laryngoscope 2006;116:1-11. [DOI: 10.1097/01.mlg.0000200428.26975.86] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 4.7] [Reference Citation Analysis]
154 Fitzgerald RC, Caldas C. Familial gastric cancer - clinical management. Best Pract Res Clin Gastroenterol 2006;20:735-43. [PMID: 16997157 DOI: 10.1016/j.bpg.2006.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
155 Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006;20:651-74. [PMID: 16997151 DOI: 10.1016/j.bpg.2006.03.016] [Cited by in Crossref: 106] [Cited by in F6Publishing: 115] [Article Influence: 6.2] [Reference Citation Analysis]
156 Rosivatz E, Becker K, Kremmer E, Schott C, Blechschmidt K, Höfler H, Sarbia M. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch 2006;448:277-87. [DOI: 10.1007/s00428-005-0118-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 3.1] [Reference Citation Analysis]
157 Cacev T, Jokić M, Spaventi R, Pavelić K, Kapitanović S. Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms. J Cancer Res Clin Oncol 2006;132:200-4. [PMID: 16283382 DOI: 10.1007/s00432-005-0051-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
158 Ferreira P, Oliveira MJ, Beraldi E, Mateus AR, Nakajima T, Gleave M, Yokota J, Carneiro F, Huntsman D, Seruca R, Suriano G. Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Experimental Cell Research 2005;310:99-104. [DOI: 10.1016/j.yexcr.2005.07.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
159 Stock M, Otto F. Gene deregulation in gastric cancer. Gene. 2005;360:1-19. [PMID: 16154715 DOI: 10.1016/j.gene.2005.06.026] [Cited by in Crossref: 79] [Cited by in F6Publishing: 93] [Article Influence: 4.4] [Reference Citation Analysis]
160 Liu YC, Shen CY, Wu HS, Chan DC, Chen CJ, Yu JC, Yu CP, Harn HJ, Shyu RY, Shih YL, Hsieh CB, Hsu HM. Helicobacter pylori infection in relation to E-cadherin gene promoter polymorphism and hypermethylation in sporadic gastric carcinomas. World J Gastroenterol 2005; 11(33): 5174-5179 [PMID: 16127748 DOI: 10.3748/wjg.v11.i33.5174] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
161 Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005;18:741-51. [PMID: 15696125 DOI: 10.1038/modpathol.3800362] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 4.6] [Reference Citation Analysis]
162 Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005;25:197-222. [PMID: 15749238 DOI: 10.1016/j.cll.2004.12.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
163 van Velthuysen ML, Taal BG, van der Hoeven JJ, Peterse JL. Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma. Histopathology 2005;46:153-7. [PMID: 15693887 DOI: 10.1111/j.1365-2559.2005.02062.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
164 Zheng ZH, Sun XJ, Zhou HT, Shang C, Ji H, Sun KL. Analysis of metastasis suppressing function of E-cadherin in gastric cancer cells by RNAi. World J Gastroenterol 2005; 11(13): 2000-2003 [PMID: 15800994 DOI: 10.3748/wjg.v11.i13.2000] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
165 Moran C, Joyce M, Mcanena O. CDH1 associated gastric cancer: a report of a family and review of the literature. European Journal of Surgical Oncology (EJSO) 2005;31:259-64. [DOI: 10.1016/j.ejso.2004.12.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
166 Gamboa-Dominguez A, Dominguez-Fonseca C, Chavarri-Guerra Y, Vargas R, Reyes-Gutierrez E, Green D, Quintanilla-Martinez L, Luber B, Busch R, Becker KF, Becker I, Höfler H, Fend F. E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival. Hum Pathol 2005;36:29-35. [PMID: 15712179 DOI: 10.1016/j.humpath.2004.09.020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
167 Nakamura E, Sugihara H, Bamba M, Hattori T. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol. 2005;205:349-358. [PMID: 15682444 DOI: 10.1002/path.1718] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
168 Lu Y, Xu YC, Shen J, Yu RB, Niu JY, Guo JT, Hu X, Shen HB. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005; 11(1): 56-60 [PMID: 15609397 DOI: 10.3748/wjg.v11.i1.56] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
169 Baldwin L, Lee AHS, Al-talib RK, Theaker JM. Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 2005;46:50-6. [DOI: 10.1111/j.1365-2559.2005.02051.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
170 Luber B, Gamboa-dominguez A, Becker K, Fend F, Höfler H. 11 Role of Immunohistochemical Expression of E-Cadherin in Diffuse-Type Gastric Cancer. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma 2005. [DOI: 10.1016/s1874-5784(05)80073-x] [Reference Citation Analysis]
171 Van Marck VL, Bracke ME. Epithelial-Mesenchymal Transitions in Human Cancer. Rise and Fall of Epithelial Phenotype 2005. [DOI: 10.1007/0-387-28671-3_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
172 Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S, Gilchrist D, Hughes R, Jackson CE, Monaghan KG, Oliveira MJ, Seruca R, Gallinger S, Caldas C, Huntsman D. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41:508-517. [PMID: 15235021 DOI: 10.1136/jmg.2004.018275] [Cited by in Crossref: 265] [Cited by in F6Publishing: 292] [Article Influence: 13.9] [Reference Citation Analysis]
173 Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R, Cascinu S. Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat Rev. 2004;30:451-459. [PMID: 15245777 DOI: 10.1016/j.ctrv.2004.01.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
174 Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol. 2004;15:489-492. [PMID: 14998854 DOI: 10.1093/annonc/mdh108] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
175 Gopalakrishna Iyer N, Caldas C. Gastric Cancer — Keeping It in the Family. Cancer Rev A P 2004;02:69-79. [DOI: 10.1142/s021983630400038x] [Reference Citation Analysis]
176 Kim TY, Jong HS, Jung Y, Kim TY, Kang GH, Bang YJ. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 2004;20 Suppl 1:131-42. [PMID: 15298619 DOI: 10.1111/j.1365-2036.2004.01984.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
177 Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004;53:814-20. [PMID: 15138207 DOI: 10.1136/gut.2002.010447] [Cited by in Crossref: 135] [Cited by in F6Publishing: 128] [Article Influence: 7.1] [Reference Citation Analysis]
178 Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004;53:814-20. [PMID: 15138207 DOI: 10.1136/gut.2002.010447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell. 2004;5:121-125. [PMID: 14998488 DOI: 10.1016/s1535-6108(04)00033-9] [Cited by in Crossref: 205] [Cited by in F6Publishing: 181] [Article Influence: 10.8] [Reference Citation Analysis]
180 Oliveira C, Suriano G, Ferreira P, Canedo P, Kaurah P, Mateus R, Ferreira A, Ferreira AC, Oliveira MJ, Figueiredo C, Carneiro F, Keller G, Huntsman D, Machado JC, Seruca R. Genetic screening for familial gastric cancer. Hered Cancer Clin Pract 2004;2:51-64. [PMID: 20233471 DOI: 10.1186/1897-4287-2-2-51] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
181 Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol. 2003;14:1705-1713. [PMID: 14630673 DOI: 10.1093/annonc/mdg486] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 5.4] [Reference Citation Analysis]
182 Sudo M, Chong JM, Sakuma K, Ushiku T, Uozaki H, Nagai H, Funata N, Matsumoto Y, Fukayama M. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2004;109:194-199. [PMID: 14750169 DOI: 10.1002/ijc.11701] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 2.9] [Reference Citation Analysis]
183 Ling XL, Fang DC, Wang RQ, Yang SM, Fang L. Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions. World J Gastroenterol 2004; 10(6): 800-803 [PMID: 15040020 DOI: 10.3748/wjg.v10.i6.800] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
184 Carneiro F, Machado JC, Nabais S, Santos CM, Sobrinho Simões M. Mixed carcinoma of the stomach: a clinicopathological entity. Histopathology 2003;43:94-5. [PMID: 12823718 DOI: 10.1046/j.1365-2559.2003.01617.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
185 Peng D, Sugihara H, Mukaisho K, Ling Z, Hattori T. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization. J Pathol 2004;203:884-95. [DOI: 10.1002/path.1586] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
186 Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol. 2003;163:847-857. [PMID: 14623871 DOI: 10.1083/jcb.200308162] [Cited by in Crossref: 371] [Cited by in F6Publishing: 389] [Article Influence: 18.6] [Reference Citation Analysis]
187 Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Kohshi K, Osada Y, Katoh T. E-cadherin gene polymorphism and risk of urothelial cancer. Cancer Lett. 2003;195:53-58. [PMID: 12767511 DOI: 10.1016/s0304-3835(03)00130-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
188 Suriano G, Mulholland D, de Wever O, Ferreira P, Mateus AR, Bruyneel E, Nelson CC, Mareel MM, Yokota J, Huntsman D, Seruca R. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene 2003;22:5716-9. [PMID: 12944922 DOI: 10.1038/sj.onc.1206672] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
189 Chan AO, Chu KM, Lam SK, Wong BC, Kwok KF, Law S, Ko S, Hui WM, Yueng YH, Wong J. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer. J Clin Oncol. 2003;21:2288-2293. [PMID: 12805328 DOI: 10.1200/jco.2003.08.078] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 2.6] [Reference Citation Analysis]
190 Carvalho B, Pinto M, Cirnes L, Oliveira C, Machado JC, Suriano G, Hamelin R, Carneiro F, Seruca R. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer. 2003;39:1222-1227. [PMID: 12763209 DOI: 10.1016/s0959-8049(03)00177-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
191 Chen JL, Chen WX, Zhu JS, Chen NW, Zhou T, Yao M, Zhang DQ, Wu YL. Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function. World J Gastroenterol 2003; 9(7): 1607-1610 [PMID: 12854175 DOI: 10.3748/wjg.v9.i7.1607] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
192 Du JJ, Dou KF, Peng SY, Xiao HS, Wang WZ, Guan WX, Wang ZH, Gao ZQ, Liu YB. cDNA suppression subtraction library for screening down-regulated genes in gastric carcinoma. World J Gastroenterol 2003; 9(7): 1439-1443 [PMID: 12854137 DOI: 10.3748/wjg.v9.i7.1439] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Bamforth F, Brown L, Senz J, Huntsman D. Mechanisms of monozygotic (MZ) twinning: A possible role for the cell adhesion molecule, E-cadherin. Am J Med Genet 2003;120A:59-62. [DOI: 10.1002/ajmg.a.20076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
194 Reis AL, Carvalheira J, Schmitt FC, Gärtner F. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours. Veterinary Record 2003;152:621-4. [DOI: 10.1136/vr.152.20.621] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
195 Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis. Hematology/Oncology Clinics of North America 2003;17:505-523. [DOI: 10.1016/s0889-8588(03)00021-2] [Reference Citation Analysis]
196 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(1): 65-71 [DOI: 10.11569/wcjd.v11.i1.65] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
197 Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Höfler H, Becker KF. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002;161:1881-1891. [PMID: 12414534 DOI: 10.1016/s0002-9440(10)64464-1] [Cited by in Crossref: 427] [Cited by in F6Publishing: 396] [Article Influence: 20.3] [Reference Citation Analysis]
198 Fang DC, Luo YH, Yang SM, Li XA, Ling XL, Fang L. Mutation analysis of APC gene in gastric cancer with microsatellite instability. World J Gastroenterol 2002; 8(5): 787-791 [PMID: 12378616 DOI: 10.3748/wjg.v8.i5.787] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 53] [Article Influence: 2.2] [Reference Citation Analysis]
199 Azarschab P, Porschen R, Gregor M, Blin N, Holzmann K. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Genes Chromosomes Cancer 2002;35:121-6. [PMID: 12203775 DOI: 10.1002/gcc.10101] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.4] [Reference Citation Analysis]
200 Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer. 2002;100:683-685. [PMID: 12209606 DOI: 10.1002/ijc.10541] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
201 Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis. Gastroenterol Clin North Am 2002;31:517-35, x. [PMID: 12134616 DOI: 10.1016/s0889-8553(02)00012-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]
202 El-rifai W, Powell SM. Molecular and biologic basis of upper gastrointestinal malignancy. Surgical Oncology Clinics of North America 2002;11:273-91. [DOI: 10.1016/s1055-3207(02)00004-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
203 Peinado H, Cano A. Epigenetic Regulation of the E-Cadherin Cell-Cell Adhesion Gene. In: Esteller M, editor. DNA Methylation, Epigenetics and Metastasis. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 157-90. [DOI: 10.1007/1-4020-3642-6_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]